BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 2140670)

  • 21. Childhood Alopecia Areata: An Overview of Treatment and Recent Patents.
    Hon KL; Luk DCK; Leung AKC; Ng C; Loo SKF
    Recent Pat Inflamm Allergy Drug Discov; 2020; 14(2):117-132. PubMed ID: 32723274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An immunologic mechanism for the therapeutic efficacy of minoxidil in alopecia areata.
    Namazi MR; Handjani F
    J Drugs Dermatol; 2004; 3(2):129-30. PubMed ID: 15098965
    [No Abstract]   [Full Text] [Related]  

  • 23. A randomized trial of diphenylcyclopropenone (DPCP) combined with anthralin versus DPCP alone for treating moderate to severe alopecia areata.
    Ghandi N; Daneshmand R; Hatami P; Abedini R; Nasimi M; Aryanian Z; Vance TM
    Int Immunopharmacol; 2021 Oct; 99():107971. PubMed ID: 34298402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of alopecia areata with nonablative fractional laser combined with topical minoxidil.
    Wang W; Gegentana ; Tonglaga ; Bagenna ; Li Y
    J Cosmet Dermatol; 2019 Aug; 18(4):1009-1013. PubMed ID: 31245963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Double-blind, placebo-controlled evaluation of topical minoxidil in extensive alopecia areata.
    Price VH
    J Am Acad Dermatol; 1987 Mar; 16(3 Pt 2):730-6. PubMed ID: 3549809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of severe alopecia areata with topical diphenylcyclopropenone and 5% minoxidil: a clinical and immunopathologic evaluation.
    Shapiro J; Tan J; Ho V; Tron V
    J Invest Dermatol; 1995 May; 104(5 Suppl):36S. PubMed ID: 7738390
    [No Abstract]   [Full Text] [Related]  

  • 27. Response to minoxidil in severe alopecia areata correlates with T lymphocyte stimulation.
    Fiedler-Weiss VC; Buys CM
    Br J Dermatol; 1987 Dec; 117(6):759-63. PubMed ID: 3501310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recalcitrant alopecia areata responsive to leflunomide and anthralin-Potentially undiscovered JAK/STAT inhibitors?
    Sardana K; Gupta A; Gautam RK
    Pediatr Dermatol; 2018 Nov; 35(6):856-858. PubMed ID: 30318623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of hair loss.
    Price VH
    N Engl J Med; 1999 Sep; 341(13):964-73. PubMed ID: 10498493
    [No Abstract]   [Full Text] [Related]  

  • 30. Platelets rich plasma versus minoxidil 5% in treatment of alopecia areata: A trichoscopic evaluation.
    El Taieb MA; Ibrahim H; Nada EA; Seif Al-Din M
    Dermatol Ther; 2017 Jan; 30(1):. PubMed ID: 27791311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Topical immunotherapy in combination with anthralin in the treatment of refractory alopecia areata.
    Kagami S; Kishi Y; Hino H
    J Cosmet Dermatol; 2020 Sep; 19(9):2411-2414. PubMed ID: 32621407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topical minoxidil in the treatment of alopecia areata and male-pattern alopecia.
    Shi YP
    Arch Dermatol; 1986 May; 122(5):506. PubMed ID: 3707163
    [No Abstract]   [Full Text] [Related]  

  • 33. 3 percent topical minoxidil compared with placebo for the treatment of chronic severe alopecia areata.
    Fransway AF; Muller SA
    Cutis; 1988 Jun; 41(6):431-5. PubMed ID: 3292159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topical minoxidil in alopecia areata: no effect on the perifollicular lymphoid infiltration.
    Khoury EL; Price VH; Abdel-Salam MM; Stern M; Greenspan JS
    J Invest Dermatol; 1992 Jul; 99(1):40-7. PubMed ID: 1607678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of azelaic acid and anthralin for the therapy of patchy alopecia areata: a pilot study.
    Sasmaz S; Arican O
    Am J Clin Dermatol; 2005; 6(6):403-6. PubMed ID: 16343028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence-based treatment of alopecia areata.
    Epstein E
    J Am Acad Dermatol; 2001 Oct; 45(4):640-2. PubMed ID: 11568768
    [No Abstract]   [Full Text] [Related]  

  • 37. Restoration of hair growth in mice with an alopecia areata-like disease using topical anthralin.
    Tang L; Cao L; Sundberg JP; Lui H; Shapiro J
    Exp Dermatol; 2004 Jan; 13(1):5-10. PubMed ID: 15009110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topical minoxidil in extensive alopecia areata, including 3-year follow-up.
    Price VH
    Dermatologica; 1987; 175 Suppl 2():36-41. PubMed ID: 3691913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current treatment of alopecia areata.
    Shapiro J
    J Investig Dermatol Symp Proc; 2013 Dec; 16(1):S42-4. PubMed ID: 24326551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Retrospective Review of Anthralin in Petrolatum in the Treatment of Alopecia Areata in the Pediatric Population.
    Zafrir Y; Tantuco K; Tangtatco AJA; Ho N
    J Cutan Med Surg; 2023; 27(5):449-453. PubMed ID: 37559401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.